Open AccessA systems medicine approach for finding target proteins affecting treatment outcomes in patients with non-Hodgkin lymphoma
Author(s) -
Faezeh Ajorloo,
Mohammad Vaezi,
Alireza Saadat,
Seyed Reza Safaee,
Behrouz Gharib,
Mostafa Ghanei,
Seyed Davar Siadat,
Farzam Vaziri,
Abolfazl Fateh,
Mehrdad Pazhouhandeh,
Behrouz Vaziri,
Reza Moazemi,
Fereidoun Mahboudi,
Fatemeh Rahimi Jamnani
Publication year - 2017
Publication title -
plos one
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.99
H-Index - 332
ISSN - 1932-6203
DOI - 10.1371/journal.pone.0183969
Subject(s) - kegg , wnt signaling pathway , cancer research , signal transduction , biology , lymphoma , cetuximab , cancer , bioinformatics , medicine , computational biology , immunology , gene , genetics , transcriptome , colorectal cancer , gene expression
Autoantibody profiling with a systems medicine approach can help identify critical dysregulated signaling pathways (SPs) in cancers. In this way, immunoglobulins G (IgG) purified from the serum samples of 92 healthy controls, 10 pre-treated (PR) non-Hodgkin lymphoma (NHL) patients, and 20 NHL patients who underwent chemotherapy (PS) were screened with a phage-displayed random peptide library. Protein-protein interaction networks of the PR and PS groups were analyzed and visualized by Gephi. The results indicated AXIN2, SENP2, TOP2A, FZD6, NLK, HDAC2, HDAC1, and EHMT2, in addition to CAMK2A, PLCG1, PLCG2, GRM5, GRIN2B, GRIN2D, CACNA2D3, and SPTAN1 as hubs in 11 and 7 modules of PR and PS networks, respectively. PR- and PS-specific hubs were evaluated in the Kyoto Encyclopedia of Genes and Genomes (KEGG) and Reactome databases. The PR-specific hubs were involved in Wnt SP, signaling by Notch1 in cancer, telomere maintenance, and transcriptional misregulation. In contrast, glutamate receptor SP, Fc receptor-related pathways, growth factors-related SPs, and Wnt SP were statistically significant enriched pathways, based on the pathway analysis of PS hubs. The results revealed that the most PR-specific proteins were associated with events involved in tumor development, while chemotherapy in the PS group was associated with side effects of drugs and/or cancer recurrence. As the findings demonstrated, PR- and PS-specific proteins in this study can be promising therapeutic targets in future studies.